Jones Day's PTAB Litigation Blog, Home page
PTAB Upholds Patent Claims on Methods of Using Ravicti®

PTAB Upholds Patent Claims on Methods of Using Ravicti®

By Irina Britva, Ph.D. and Cary Miller, Ph.D. On November 3, 2016, the PTAB issued a Final Written Decision upholding a Horizon Therapeutics LLC (“Horizon”) patent, U.S. 8,642,012 (the ’012 patent), relating to use of Ravicti® (glycerol phenylbutyrate) for treating...

read more

About this blog

Archives